The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin, at the American Heart Association Scientific ...

Dexcom and ŌURA have partnered to integrate Dexcom's glucose biosensing feature with the ŌURA Ring's health metrics to help ...

URA, which is now valued at more than $5bn, is set to integrate Dexcom’s glucose capabilities with the Oura ring.

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, and ŌURA, maker of the world’s leading smart ring, ...

Smart ring maker Oura and glucose monitoring giant Dexcom just struck a partnership that will allow the company's products to ...

Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom.

Oura recently introduced its fourth-generation smart ring, but now it’s focusing on a new partnership with another giant in ...

Oura is partnering with medical device maker Dexcom to integrate data from glucose biosensors with the Oura Ring, which ...

Smart ring company Oura announced it received $75 million in funding from glucose monitoring and diagnostics company Dexcom.

Dexcom (Nasdaq:DXCM) announced today that it entered into a strategic partnership with Oura, maker of leading smart ring ...

Dexcom has invested $75 million into Oura, which values Oura at $5 billion. And the details of the deal could have a ...

DexCom invests $75M in Finnish health tech firm ŌURA, forming a strategic partnership to integrate glucose data with vital signs and biometrics.